Surety medicine focuses on protecting the health of the personnel who deal with nuclear, biological or chemical materials, and on medical requirement compliance to help ensure the security of the materials and the work force.

August 2025 Surety Medicine Teleconference

Red Blood Cell Cholinesterase Monitoring:
What Every Competent Medical Authority Should Know

Wednesday, 20 August 2025 will bring the next monthly Surety Medicine Teleconference at 1 pm (1300 hrs) Eastern Time. The topic for August is “Red Blood Cell Cholinesterase Monitoring: What Every CMA Should Know." The presenter will be the Senior Occupational Health Physician for the Army Office of The Surgeon General Surety Medicine Branch.

To request additional information, email the Army Surety Medicine Branch at:

usarmy.jbsa.medcom-hq.mbx.surety-medicine@army.mil

FY25 Surety Medicine Teleconferences

Presentation Title Date
Red Blood Cell Cholinesterase Monitoring: 08/20/2025 What Every CMA Should Know Hearing in Noise Testing 09/17/2025
_________________________________________ FY26 Surety Medicine Teleconferences Presentation Title Date Medical Policy Guidance for PRP Relevant Information 15 OCT 2025 Documentation, Assessment, and Reporting to Certifying Officials Cardiovascular Screening (includes MIs, Arrhythmias, 19 NOV 2025 Stents, PCIs, and CABGs) Hazard-specific Medical Surveillance Examinations 17 DEC 2025 (Chemical, Biological, Nuclear) Potential Exposure Evaluations 21 JAN 2026 Worksite Visits (Planning, Conducting, Documenting) 18 FEB 2026 Fitness For Duty Evaluations (5 CFR 339) 18 MAR 2026 Chemical, Biological, Nuclear Incident/Mishap 15 APR 2026 Response and Assistance Sleep Disordered Breathing, OSA, and the PRP 20 MAY 2026 MHS Genesis, Medical Record Audits, Peer Review, 17 JUN 2026 Quality Assurance Checks in PRP records Respiratory Protection Program, Respirator Clearances, 15 JUL 2026 and Respirator Use Testing PRP Mental Health Reliability Screening 19 AUG 2026 Advanced Life Support Pre-Hospital Care (Capnography, 16 SEP 2026 Ventilation, Emergency Respiratory Support)

--ALERT--

NERVE AGENT ANTIDOTE SHELF LIFE EXTENSION PROGRAM

Specific lots of DuoDote(R) combined nerve agent antidote auto-injectors were approved for shelf life extensions beyond labeled expiration dates; all of these have now expired.

NO PREVIOUSLY EXTENDED NERVE AGENT
ANTIDOTES ARE NOW APPROVED FOR USE.

Previously, the U.S. Food and Drug Administration (FDA) provided extended expiry dates for specific lots of AtroPen (atropine), CANA (diazepam), DuoDote, morphine sulfate, and pralidoxime chloride auto-injectors. However, because no further expiry dating extensions of these lots are possible, FDA is alerting civilian health care professionals and emergency responders that all of these extended lots are no longer useable and should be properly disposed of.

Complete FDA information related to the auto-injector shelf life extension program can be found at this FDA Drug Safety Page.

Surety Medicine

August 2025 Surety Medicine Teleconference

Red Blood Cell Cholinesterase Monitoring:What Every Competent Medical Authority Should Know

To request additional information, email the Army Surety Medicine Branch at:

usarmy.jbsa.medcom-hq.mbx.surety-medicine@army.mil​

​

FY25 Surety Medicine Teleconferences

​Presentation Title Date

_________________________________________

FY26 Surety Medicine Teleconferences